US Patent Issued to Ascentage Pharma (Suzhou), Ascentage Pharma Group on Sept. 8 for "Microsuspension of an MDM2 inhibitor and therapeutic applications thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,113, issued on Sept. 8, was assigned to Ascentage Pharma (Suzhou) Co. Ltd. (China) and Ascentage Pharma Group Corp Ltd. (China).

"Microsuspension of an MDM2 inhibitor and therapeutic applications thereof" was invented by Saijie Zhu (Suzhou, China), Douglas Dong Fang (Suzhou, China), Yifan Zhai (Suzhou, China) and Dajun Yang (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a microsuspension of an MDM2 inhibitor, comprising microparticles of the MDM2 inhibitor, e.g., a compound of Formula (I), a surfactant, and a tonicity agent. Also provided herein is a method of treating an MDM2-mediated disorder, disease, or conditio...